Publications by authors named "Robert Heelan"

Claim this Profile
A
A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumonia.
Marc B Feinstein, Shilpa A DeSouza, Andre L Moreira, Diane E Stover, Robert T Heelan

J Clin Pathol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
Paul K Paik, Leonard P James, Gregory J Riely, Christopher G Azzoli, Vincent A Miller, Robert T Heelan

Cancer Chemother Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene.
Naiyer A Rizvi, Valerie Rusch, William Pao, Jamie E Chaft, Marc Ladanyi, Robert T Heelan

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.
Katharine A Price, Christopher G Azzoli, Lee M Krug, Maria C Pietanza, Naiyer A Rizvi, Robert T Heelan

J Thorac Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.
Maureen F Zakowski, Sanaa Hussain, William Pao, Marc Ladanyi, Michelle S Ginsberg, Robert Heelan

Arch Pathol Lab Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
Vincent A Miller, Gregory J Riely, Maureen F Zakowski, Allan R Li, Jyoti D Patel, Robert T Heelan

J Clin Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
Naiyer A Rizvi, Gregory J Riely, Christopher G Azzoli, Vincent A Miller, Kenneth K Ng, Robert Heelan

J Clin Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.
Daniel T Milton, Gregory J Riely, Christopher G Azzoli, Jorge E Gomez, Robert T Heelan

Cancer· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma.
Lee M Krug, Robert T Heelan, Mark G Kris, Ennapadam Venkatraman, F M Sirotnak

J Thorac Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer.
Michelle S Ginsberg, Ravinder K Grewal, Robert T Heelan

Radiol Clin North Am· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.
David R Gandara, Denise Aberle, Derick Lau, James Jett, Tim Akhurst, Robert Heelan

J Thorac Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular on/off switch.
Daniel T Milton, Gregory J Riely, William Pao, Vincent A Miller, Mark G Kris, Robert T Heelan

J Clin Oncol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer.
Daniel T Milton, Christopher G Azzoli, Robert T Heelan, Ennapadam Venkatraman, Jorge E Gomez

Cancer· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.
Raja M Flores, Lee M Krug, Kenneth E Rosenzweig, Ennapadam Venkatraman, Alain Vincent, Robert Heelan

J Thorac Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.
Lee M Krug, Vincent A Miller, Jyoti Patel, John Crapanzano, Christopher G Azzoli, Robert T Heelan

Cancer· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.
Lee M Krug, John P Crapanzano, Christopher G Azzoli, Vincent A Miller, Naiyer Rizvi, Robert T Heelan

Cancer· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of type of cigarette on peripheral versus central lung cancer.
Daniel R Brooks, John H M Austin, Robert T Heelan, Michelle S Ginsberg, Victor Shin

Cancer Epidemiol Biomarkers Prev· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical management of patients with non-small-cell lung cancer treated with gefitinib.
Neelam T Shah, Mark G Kris, William Pao, Leslie B Tyson, Barbara M Pizzo, Robert T Heelan

J Clin Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.
William Pao, Theresa Y Wang, Gregory J Riely, Vincent A Miller, Qiulu Pan, Robert T Heelan

PLoS Med· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.
William Pao, Vincent Miller, Maureen Zakowski, Jennifer Doherty, Katerina Politi, Robert Heelan

Proc Natl Acad Sci U S A· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staging and response to therapy of malignant pleural mesothelioma.
Robert Heelan

Lung Cancer· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.
Vincent A Miller, Mark G Kris, Neelam Shah, Jyoti Patel, Christopher Azzoli, Robert T Heelan

J Clin Oncol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.
Carolyn E Reed, David H Harpole, Katherine E Posther, Sandra L Woolson, Robert J Downey, Robert T Heelan

J Thorac Cardiovasc Surg· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot trial of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib plus carboplatin and paclitaxel in patients with stage IIIB or IV non-small-cell lung cancer.
Vincent A Miller, David H Johnson, Lee M Krug, Barbara Pizzo, Leslie Tyson, Robert T Heelan

J Clin Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overdiagnosis in chest radiographic screening for lung carcinoma: frequency.
David F Yankelevitz, William J Kostis, Claudia I Henschke, Robert T Heelan, Daniel M Libby

Cancer· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis